Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
Public ClinicalTrials.gov record NCT03964727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-Label Study of Sacituzumab Govitecan (IMMU-132) in Subjects With Metastatic Solid Tumors
Study identification
- NCT ID
- NCT03964727
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Interventions
- Sacituzumab Govitecan-hziy Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 14, 2019
- Primary completion
- Jan 14, 2025
- Completion
- Nov 30, 2026
- Last update posted
- Apr 27, 2026
2019 – 2026
United States locations
- U.S. sites
- 31
- U.S. states
- 21
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Oncology & Hematology, LLC | Anchorage | Alaska | 99508 | — |
| USOR - Arizona Oncology - Glendale - Saguaro Cancer Center | Glendale | Arizona | 85308 | — |
| Arizona Oncology Associates PC-HAL | Goodyear | Arizona | 85395 | — |
| Highlands Oncology Group | Springdale | Arkansas | 72762 | — |
| UCLA Hematology/Oncology | Los Angeles | California | 90095 | — |
| TRIO-US Central Administration | Whittier | California | 90602 | — |
| University of Colorado Hospital - Anschutz Cancer Pavilion | Aurora | Colorado | 80045 | — |
| Smilow Cancer Hospital at Yale | New Haven | Connecticut | 06520 | — |
| SIU School of Medicine, Simmons Cancer Institute at SIU | Springfield | Illinois | 62702 | — |
| PathGroup Labs, LLC | Fort Wayne | Indiana | 46804 | — |
| Parkview Research Center | Fort Wayne | Indiana | 46845 | — |
| University of Kentucky Medical Center | Lexington | Kentucky | 40536 | — |
| Christus Highland Cancer Treatment Center | Shreveport | Louisiana | 71105 | — |
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| North Mississippi Medical Center - Hematology and Oncology - Tupelo | Tupelo | Mississippi | 38801 | — |
| Washington University School of Medicine - Siteman Cancer Center | St Louis | Missouri | 63110 | — |
| David C. Pratt Center | St Louis | Missouri | 63141 | — |
| Comprehensive Cancer of Nevada | Las Vegas | Nevada | 89052 | — |
| New York Oncology Hematology - Albany Medical Center | Albany | New York | 12208 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Weill Cornell Medicine - Upper East Side | New York | New York | 10065 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Willamette Valley Cancer Institute and Research Center - Eugene | Eugene | Oregon | 97401 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Texas Oncology - Tyler | Tyler | Texas | 75702 | — |
| Blue Ridge Cancer Care - Wytheville | Blacksburg | Virginia | 24060 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | — |
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03964727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03964727 live on ClinicalTrials.gov.